Iberia Pharmaceuticals is going to open a high-tech manufacturing and research facility of 60,000 sq ft with an investment of Rs 70 crore in Jhajjar, Haryana. It will be operational by mid -2026. This will provide employment to more than 600 people.
Iberia pharmaceuticals: Iberia Pharmaceuticals, a leading company in the field of skin care, is going to invest in Jhajjar, Haryana. There will be a new high-tech manufacturing and research facility in 60 thousand square feet here. It is expected to be operational by mid -2026. This facility is designed to provide science -based, skin -based, healthy products to customers. The company has invested Rs 70 crore. This will strengthen the Make in India initiative of the Government of India.
This unit will be equipped with the best control systems and equipment of its category. It will receive the support of an experienced team that will run a large -scale commercial manufacturing smoothly. In the scale of manufacturing, there will be no compromise on the international standards of quality control. The plant will focus on providing economically viable solutions, strong, compliant and environmentally in a sustainable manner.
Its purpose is to help customers who are looking for highly effective and personal skin care products. Research lab markets with high technology, focusing on research and development, will help in constantly monitoring customers’ demand, product development and prudent formulation reforms.
This new feature complements the current search capabilities and infrastructure of Iberia. This includes clinical-grade treatment. It mainly focuses on nano-technology-based skin care solutions and medical solutions with strong pharmaceutical base. These products are vegetarian and are designed for high-demonstration skin care in various categories.
Nitin Jain, founder of Iberia Pharmaceuticals Nitin Jain said, “By bringing global manufacturing quality to India, we are building faith, capacity and a future where healthcare will be based on high standards. This new plant is an important milestone in our development journey. It will fully complose the global regulator standards.”
He said, “This new feature is one of the many strategic initiatives being implemented by Iberia to promote rapid growth. It also shows our strong commitment to the continuous expansion of our business. We will enable us to serve our global customers efficiently. We support our newly-classical products to improve healthcare and make us fulfill our newly. The convenience is very excited to start work. This facility will provide employment to more than 600 people.
Sourav Ojha, co-founder of Iberia Pharmaceuticals, said, “Iberia believes in intensive research of science-supported skin care. Using state-of-the-art nano technology brings products that are carrying forward the limitations of innovation. Our aim is clear in pharmaceuticals.
Iberia Pharmaceuticals is reliable name in Skincare
Iberia Pharmaceuticals is a reliable name in pharma-grade skincare. It provides new and reliable products for healthy skin. This brand prepares formulas keeping the real skin in mind and is known for its commitment to quality and efficacy. This brand specializes in the development of science-based products, focusing on skin health rather than trendy products. Skincare for Iberia is not only about making a product, but about the commitment of the right behavior for customers using its products.
Iberia pharmaceuticals also bring clinically tested and reliable brands for people of India. These include Cesdarma, Mediderma, Dermpix, Noreva, Metacair. Iberia has been engaged in fulfilling the needs related to India and the world for many decades. Gradually, credibility is becoming synonymous in the field of dermatology and health.